Skip to main content
. 2024 Sep 12;9(12):3439–3445. doi: 10.1016/j.ekir.2024.08.033

Figure 1.

Figure 1

Flowchart of patient inclusion. ∗Some patients were not eligible because of inability to consent (dementia and old age) or comorbidity (malignancy, systemic disease, diabetes). CP, cyclophosphamide; MN, membranous nephropathy; Pred, prednisone; RTX, rituximab.